BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Bio-Techne (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will deliver a presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Tuesday, January 14, 2025, at 10:30 a.m. PST. Interested parties can access a live webcast of the presentation through Bio-Techne's Investor Relations website's IR Calendar page.
Bio-Techne (NASDAQ: TECH) ha annunciato che il suo Presidente e CEO, Kim Kelderman, terrà una presentazione durante la 43ª Conferenza Sanitaria Annuale J.P. Morgan. La presentazione è programmata per martedì 14 gennaio 2025, alle 10:30 PST. Le parti interessate possono accedere a una trasmissione in diretta della presentazione attraverso la pagina del Calendario IR del sito delle Relazioni con gli Investitori di Bio-Techne.
Bio-Techne (NASDAQ: TECH) ha anunciado que su Presidente y CEO, Kim Kelderman, realizará una presentación en la 43ª Conferencia Anual de Salud J.P. Morgan. La presentación está programada para el martes 14 de enero de 2025, a las 10:30 a.m. PST. Las partes interesadas pueden acceder a una transmisión en vivo de la presentación a través de la página del Calendario IR en el sitio web de Relaciones con Inversores de Bio-Techne.
Bio-Techne (NASDAQ: TECH)는 Kim Kelderman 사장이 43회 JP 모건 헬스케어 연례 회의에서 발표를 할 것이라고 발표했습니다. 발표는 2025년 1월 14일 화요일, 오전 10:30 PST로 예정되어 있습니다. 관심 있는 분들은 Bio-Techne의 투자자 관계 웹사이트 IR 캘린더 페이지를 통해 발표의 실시간 웹캐스트에 접근할 수 있습니다.
Bio-Techne (NASDAQ: TECH) a annoncé que son Président et CEO, Kim Kelderman, donnera une présentation lors de la 43ème Conférence Annuelle J.P. Morgan sur la Santé. La présentation est prévue pour mardi 14 janvier 2025, à 10h30 PST. Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la page Calendrier IR du site des Relations Investisseurs de Bio-Techne.
Bio-Techne (NASDAQ: TECH) hat angekündigt, dass sein Präsident und CEO, Kim Kelderman, eine Präsentation auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz halten wird. Die Präsentation ist für Dienstag, den 14. Januar 2025, um 10:30 Uhr PST geplant. Interessierte Parteien können über die IR-Kalenderseite der Investor-Relations-Website von Bio-Techne auf einen Live-Stream der Präsentation zugreifen.
- None.
- None.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-43rd-annual-jp-morgan-healthcare-conference-302335119.html
SOURCE Bio-Techne Corporation
FAQ
When will Bio-Techne (TECH) present at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Bio-Techne's (TECH) J.P. Morgan Healthcare Conference presentation?
Who will represent Bio-Techne (TECH) at the 2025 J.P. Morgan Healthcare Conference?
Which annual J.P. Morgan Healthcare Conference will Bio-Techne (TECH) attend in 2025?
